1. Septic Shock After Kidney Transplant: A Rare Bloodstream Ralstonia mannitolilytica Infection
- Author
-
Tian,Xiangyong, Jing,Nan, Duan,Wenjing, Wu,Xiaoqiang, Zhang,Chan, Wang,Shanmei, Yan,Tianzhong, Tian,Xiangyong, Jing,Nan, Duan,Wenjing, Wu,Xiaoqiang, Zhang,Chan, Wang,Shanmei, and Yan,Tianzhong
- Abstract
Xiangyong Tian,1,* Nan Jing,2,* Wenjing Duan,3 Xiaoqiang Wu,1 Chan Zhang,1 Shanmei Wang,2 Tianzhong Yan1 1Department of Urology, Henan Provincial Peopleâs Hospital, Zhengzhou University Peopleâs Hospital, Henan University Peopleâs Hospital, Zhengzhou, Peopleâs Republic of China; 2Department of Clinical Microbiology, Henan Provincial Peopleâs Hospital, Zhengzhou University Peopleâs Hospital, Henan University Peopleâs Hospital, Zhengzhou, Peopleâs Republic of China; 3Department of the Clinical Research Center, Henan Provincial Peopleâs Hospital, Zhengzhou University Peopleâs Hospital, Henan University Peopleâs Hospital, Zhengzhou, Peopleâs Republic of China*These authors contributed equally to this workCorrespondence: Tianzhong Yan, Department of Urology, Henan Provincial Peopleâs Hospital, Zhengzhou University Peopleâs Hospital, Zhengzhou, Henan Province, 450003, Peopleâs Republic of China, Email ytz460@hotmail.com Wenjing Duan, Department of the Clinical Research Center, Henan Provincial Peopleâs Hospital, Zhengzhou University Peopleâs Hospital, Zhengzhou, Henan Province, 450003, Peopleâs Republic of China, Email duanwenjingzzu@zzu.edu.cnBackground: Ralstonia mannitolilytica, an emerging opportunistic pathogen, can infect immunocompromised patients but is a rare cause of severe sepsis and septic shock in kidney transplant recipients (KTRs).Case Presentation: We present a case of septic shock after renal transplant in a 41-year-old male, which was finally proven to be caused by Ralstonia mannitolilytica through blood cultures and mass spectrometric analysis following the negative result of metagenomic next-generation sequencing (mNGS). He was finally cured after the application of sensitive antibiotics (sulfamethoxazole-trimethoprim, amikacin and piperacillin-tazobactam) based on the drug sensitivity test results. The patient had a satisfactory recovery with no complications during a 6-month follow-up period
- Published
- 2022